[1]唐鹏,姜军.类固醇受体辅活化因子家族与乳腺癌[J].中华乳腺病杂志(电子版),2007,1(1):74.
 TANG Peng,JIANG Jun.steroid receptor coactivator family and breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):74.
点击复制

类固醇受体辅活化因子家族与乳腺癌()

中华乳腺病杂志(电子版)[ISSN:1674-0807/CN:11-9146/R]

卷:
第1卷
期数:
2007年1期
页码:
74
栏目:
综述
出版日期:
2007-02-01

文章信息/Info

Title:
steroid receptor coactivator family and breast cancer
作者:
唐鹏;姜军
第三军医大学西南医院乳腺疾病中心
Author(s):
TANG Peng;JIANG Jun
关键词:
类固醇受体辅活化因子乳腺癌
摘要:
类固醇激素通过与包括ER、PR、AR、GR在内的类固醇受体结合而表现出生物学活性,在调控生长发育和多种生理机能方面起着至关重要的作用。与激素结合前,类固醇受体与辅阻遏因子结合以抑制目的基因的活性;与激素结合后,类固醇受体与辅阻遏因子解离并募集辅活化因子而获得翻译活性。所以,类固醇受体辅活化因子(steroid receptor coactivator,SRC)家族在这一过程中起重要作用。由于多种类固醇激素及其受体在乳腺癌发生、发展、治疗、预后等多个方面具有举足轻重的作用,所以SRC家族成员在其中的作用也可谓至关重要。

相似文献/References:

[1]蒋宏传.乳腺癌根治术后乳房再造方法的选择[J].中华乳腺病杂志(电子版),2007,1(1):1.
 JIANG Hong-chuan.Selection of breast reconstlh_paperctive method after radical resection in breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):1.
[2]王永胜.乳腺癌前哨淋巴结活检研究进展[J].中华乳腺病杂志(电子版),2007,1(1):7.
 YANG Ming-tian,LIAN Zheng-qiang.Advancement of endocrine therapy in breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):7.
[3]杨名添,连臻强.乳腺癌内分泌治疗的进展[J].中华乳腺病杂志(电子版),2007,1(1):14.
 WANG Yong-sheng.Advancement of sentinel lymph node in breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):14.
[4]刘鹏熙,钟少文,陈前军.乳腺癌保乳术后背阔肌微肌瓣转移乳房整形[J].中华乳腺病杂志(电子版),2007,1(1):25.
 LIAN Peng-xi,ZHONG Shao-wen,CHEN Qian-jun.The use of a lastissimus doris miniflap for immediate correction of the deformity resulting from breast conservation surgery[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):25.
[5]王毅本,盛桦,曾小兵.乳腺癌术后引流液细胞学检查得临床价值[J].中华乳腺病杂志(电子版),2007,1(1):29.
 WANG Yi-ben,SHENG Hua,ZENG Xiao-bing.Examination of exfoliative cytology of draining liquid in patients with breast tumor[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):29.
[6]王水,刘晓安,赵佳.联合法观察前哨淋巴通道的临床研究[J].中华乳腺病杂志(电子版),2007,1(1):55.
 WANG Shui,LIU Xiao-an,ZHAO Jia.The study on sentinel lymphatic channels by using methylene blue and technetium 99m sulfur colloid in breast cancer patients[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):55.
[7]曾晓华,刘长安,邓建川.RNAi 抑制hTERT基因治疗乳腺癌的实验研究[J].中华乳腺病杂志(电子版),2007,1(1):61.
 ZENG Xiao-hua,LIU Chang-an,DENG Jian-chuan.Experimental research of targeting hTERT gene inhibited in breast cancer therapy by RNA interference[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):61.
[8]陈治,耿翠芝.植物雌激素与乳腺癌关系得研究进展[J].中华乳腺病杂志(电子版),2007,1(1):67.
 CHEN Zhi,GEGN Cui-zhi.Advancement of the relationship between phytoestrogen and breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):67.
[9]徐海滨,胡组健,胡望华.乳腺癌骨转移综合治疗初探[J].中华乳腺病杂志(电子版),2007,1(1):87.
 XU Hai-bin,HU Zu-jian,HU Wang-hua.Preliminary exploration of combined therapy in bone metastasis of breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):87.
[10]张炳先,吴秀萍,蔡明勇.Ⅰ、Ⅱ期乳腺癌132例的治疗体会[J].中华乳腺病杂志(电子版),2007,1(1):90.
 ZHANG Bing-xian,WU Xiu-ping,CAI Ming-yong.Expeience of treatmen in 132 canses of stage ⅠandⅡ breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(1):90.

更新日期/Last Update: 2007-01-20